The SELECT trial demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events (heart attack, stroke, and cardiovascular death) by 20% in adults with overweight or obesity and established heart disease (Lincoff et al., SELECT trial, New England Journal of Medicine , 2023)
Headaches are a possible side effect of GLP-1, although not everyone experiences them
Orforglipron Versus Semaglutide Researchers enrolled nearly 1,700 adults with Type 2 diabetes inadequately controlled with metformin and HbA1c levels between 53 and 91 mmol/mol
Seek urgent medical attention for sudden severe headache, headache with fever or visual changes, persistent vomiting, or symptoms suggesting serious complications
Imbriani P, Martella G, Bonsi P, Pisani A (2022) Oxidative stress and synaptic dysfunction in rodent models of Parkinsons disease
This triple action counteracts the signs of aging, delivering noticeable natural results after just one treatment